Investors are mulling why Cann Global earned only $2,000 in interest in three months on $10 million in cash despite raking in interest payments a quarter earlier.
The foray into the industry comes a few months after fellow iron ore magnate Gina Rinehart put $15 million behind the European expansion of another medical cannabis player,Little Green Pharma.
ASX-listed cannabis companies are racing to get low-dose medicinal pot products onto shelves,with hopes they will be available through pharmacies by the end of next year.
Prescriptions for medicinal cannabis have almost doubled in the past year but industry leaders warn uptake is still hampered by the social stigma of the drug and lack of training for doctors.
A two-year inquiry that was set to recommend legalising cannabis in Victoria has been watered down after Labor MPs intervened at the last minute.
Cancer sufferer Kevin Jocumsen was at the end of his pain tether,but an experimental cannabis extract gave him a new lease on life. Now researchers hope it can help others too.
What does an army of Millennial investors have in common with Australia’s richest person? An appetite for investing in cannabis.
Hancock Prospecting has turned over a new leaf,investing in the blooming medicinal cannabis industry but has hit environmental regulation trouble with a Canadian coal project.
A new study has found medicinal cannabis-driving road safety risks are similar or lower than other prescription medications.
Researchers at the University of Sydney say drivers can have the intoxicating component of cannabis in their body and still be competent to drive.
Over the past five years,the combined market caps of cannabis firms have passed the billion-dollar mark - but those in the industry say patience is needed before the cash can flow.